Section 2: Selection, Procurement and Distribution 2021
DOI: 10.1136/ejhpharm-2021-eahpconf.42
|View full text |Cite
|
Sign up to set email alerts
|

3PC-067 Key role of the hospital pharmacy in a non-profit study involving ruxolitinib 5 mg CPS: implementation and quality assurance of an investigational manufacturing product

Abstract: samples. An important increase in the number of isoforms even with changes in their masses, including the main isoform, was detected. Conclusion and relevance Exposure to light may cause modifications in the nivolumab isoform profile which suggests protein degradation. This work shows the importance of protecting opened vials of the medicine Opdivo from light (and by extension, bags for infusion) when they are at room temperature (up to 25°C).

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles